A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

FASEB Journal

Volumn 18, Issue 13, 2004, Pages 1606-1608

  Bifulco, Maurizio ^a,b   Laezza, Chiara ^a   Valenti, Marta ^c   Ligresti, Alessia ^c   Portella, Giuseppe ^a   Di Marzo, Vincenzo ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AA 5 HT; ANANDAMIDE; ANTINEOPLASTIC AGENT; ARVANIL; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; FATTY ACID AMIDASE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CELL PROLIFERATION; DRUG DEGRADATION; DRUG EFFICACY; DRUG HYDROLYSIS; DRUG RECEPTOR BINDING; DRUG TUMOR LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID TUMOR; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ARACHIDONIC ACIDS; BIODEGRADATION, ENVIRONMENTAL; CELL PROLIFERATION; ENDOCANNABINOIDS; MICE; MICE, NUDE; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; SEROTONIN; THYROID NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 9444280832     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-1754fje     Document Type: Article

References (0)